Damora Therapeutics, Inc. DMRA
23.70 USD +1.84 (+8.42%)
At closeNov 6, 2026, 4:01 PM EST
23.70 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
21.13 Day range 24.16
4.95 52-week range 34.14
- YTD
- +3.00%
- 1 year
- +307.22%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -210.87M | -22.26M | -39.91M | -61.21M | -52.23M | |
| -209.84M | -21.44M | -38.35M | -61.62M | -51.75M | |
| 3.98 | -18.53 | -36.08 | -61.00 | -51.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 257.62M | 14.18M | 21.46M | 32.79M | 62.56M | |
| 260.53M | 17.13M | 38.23M | 73.19M | 122.22M | |
| 20.15M | 1.30M | 5.90M | 11.44M | 4.99M | |
| 53.00K | 61.00K | 66.00K | 328.00K | 448.00K | |
| 239.04M | 15.83M | 32.33M | 61.75M | 117.22M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -6.73M | -18.62M | -36.91M | -42.93M | -52.31M | |
| -17.37M | 11.65M | 22.33M | 12.38M | -48.05M | |
| 266.84M | 0 | 2.88M | 507.00K | 0 | |
| 242.74M | -6.97M | -11.71M | -30.04M | -100.36M |